The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period

Mycoses

Volumn 46, Issue 8, 2003, Pages 275-280

  Al Hedaithy, Saleh S A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Candida; Epidemiology; Fungemia; Saudi Arabia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHILD; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOCARDITIS; FEMALE; FREQUENCY ANALYSIS; FUNGAL STRAIN; FUNGEMIA; HUMAN; INFANT; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEWBORN; POSTOPERATIVE INFECTION; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SAUDI ARABIA; SEPTICEMIA; SPECIES; STATISTICAL DISTRIBUTION; TUBERCULOSIS; UNIVERSITY HOSPITAL; YEAST;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DIPODASCUS; DIPODASCUS CAPITATUS; ISSATCHENKIA ORIENTALIS; PICHIA; PICHIA ANOMALA; RHODOTORULA MUCILAGINOSA; TRICHOSPORON BEIGELII;

EID: 0141564612     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00893.x     Document Type: Article

References (31)

1. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary blood-stream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91 (Suppl. 3B): S86-S89.
2. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
3. Stamos JK, Rowlev AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20: 571-5.
4. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 1981; 71: 363-70.
5. Burnie JP, Odds FC, Lee W, Webster C, Williams JD. Outbreak of systemic Candida albicans infections in intensive care unit caused by cross-infection. Br Med J 1985; 290: 746-8.
6. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504-8.
7. Prasad JK, Feller I, Thomson PD. A ten-year review of Candida sepsis and mortality in burn patients. Surgery 1987; 101: 213-6.
8. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
9. Pfaller MA. Nosocomial Candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996; 22: S89-S94.
10. Voss A, Kluytmans JA, Koeleman JG et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996; 15: 909-12.
11. Sandven P, Bevanger L, Digranes A et al. Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 1998; 36: 3455-9.
12. Nguyen MH, Peacock JE, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
13. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-25.
14. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
15. Pfaller MA, Messer SA, Houston A et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998; 31: 289-96.
16. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood-stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 30: 121-9.
17. McGinnis MR. Yeast identification. In: McGinnis MR (ed.), Laboratory Handbook of Medical Mycology. New York: Academic Press. 1980: 337-410.
18. Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy - induced neutropenia and bone marrow transplantation. Emerg Infect Dis 1999; 5: 150-3.
19. Brandt ME, Harrison LH, Pass M et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000; 6: 46-49.
20. Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999; 42: 521-4.
21. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507-21.
22. Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis 1997; 28: 5-9.
23. Chakrabarti A, Ghosh A, Batra R, Kaushal A, Roy P, Singh H. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5 year period. Indian J Med Res 1996; 104: 171-6.
24. Pfaller MA, Messer SA, Hollis RJ et al. Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217-22.
25. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital; epidemiology, risk factors and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
26. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilites of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994; 38: 1422-4.
27. Colombo AL, Nucci M, Salomao R et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999; 34: 281-6.
28. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-7.
29. Sebti A, Kiehn TE, Perlin D et al. Candida dubliniensis at a cancer center. Clin Infect Dis 2001; 32: 1034-8.
30. Marriott D, Laxton M, Harkness J. Candida dubliniensis candidemia in Australia. Emerg Infect Dis 2001; 7: 479.
31. Wingard JR, Merz G, Saral R. C. tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539-43.